Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults.
about
Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic VirusInduction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccinesEngineering temperature sensitive live attenuated influenza vaccines from emerging viruses.Attenuation of equine influenza viruses through truncations of the NS1 proteinInfluenza A and B viruses expressing altered NS1 proteins: A vaccine approach.Assessment of markers of the cell-mediated immune response after influenza virus infection in frail older adults.Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young childrenCell mediated immune responses following revaccination with an influenza A/H5N1 vaccineGenetically engineered live attenuated influenza A virus vaccine candidatesAttenuated influenza virus construct with enhanced hemagglutinin protein expressionHumoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant.Increased immunogenicity of inactivated influenza virus vaccine containing purified surface antigen compared with whole virus in elderly women.Evaluating a surrogate endpoint at three levels, with application to vaccine development.Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines.Repeated influenza vaccination of healthy children and adults: borrow now, pay later?
P2860
Q30390811-5F801AB3-1F3F-40B4-82BB-260B6CF7C23DQ30408295-D130E88D-2D99-403D-A42C-AF5FE8B434DBQ30414665-B4B08A35-1692-48FB-8895-79308FBE5F76Q33843410-691BA177-05DF-40F0-B419-5ABA51AF3AD2Q33895154-46075C10-90A9-4AF2-9AF3-4CC2BF4E0700Q33999622-4276FA56-F45B-46CC-835F-F50E2AB6E91DQ35167127-5602CBDC-7878-4450-9F14-E6849BB3DC70Q35866636-D0AB235F-0825-4CBF-80A3-9B12AFFE7349Q35880481-ED6E5D67-9B20-4D2A-91EC-D47C50593B51Q35943504-2FE13C4B-4930-499D-8CD3-ADA9B3153042Q36057500-6B5515C3-D95B-433B-BFF0-384925DA3B8AQ36927062-1506A137-FC34-4DB1-A167-8935568200A1Q37107029-38CA7120-C167-4A16-B9B0-57A5E68A183AQ37655007-9DA67807-D1D6-4AA6-8984-F93C0BE194FDQ50775600-56FA821B-544F-4286-94EF-AD8A897D1149
P2860
Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Enhancement of anti-influenza ...... older, chronically ill adults.
@en
Enhancement of anti-influenza ...... older, chronically ill adults.
@nl
type
label
Enhancement of anti-influenza ...... older, chronically ill adults.
@en
Enhancement of anti-influenza ...... older, chronically ill adults.
@nl
prefLabel
Enhancement of anti-influenza ...... older, chronically ill adults.
@en
Enhancement of anti-influenza ...... older, chronically ill adults.
@nl
P2860
P1476
Enhancement of anti-influenza ...... older, chronically ill adults.
@en
P2093
P2860
P304
P407
P577
1990-11-01T00:00:00Z